Atea Pharmaceuticals, Inc.
Total Trades
16
Buys
1
Sells
9
Largest Trade
N/A
Insiders
8
Institutional Funds
81
Inst. Value
$1M+
Activist Filings
29
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director | BUY | $50K–$100K | 25K | $3.26 | Jan 17, 2025 |
| Polsky Bruce | Director | SELL | $50K–$100K | 18K | $3.49 | Jun 21, 2024 |
| Sommadossi Jean-Pierre | President | SELL | $1K–$15K | 1K | $4.00 | Jun 7, 2024 |
| Corcoran Andrea | See Remarks | EXERCISE | N/A | 44K | — | Feb 3, 2024 |
| Corcoran Andrea | See Remarks | SELL | $50K–$100K | 16K | $3.84 | Feb 3, 2024 |
| Sommadossi Jean-Pierre | President | EXERCISE | N/A | 173K | — | Feb 3, 2024 |
| Sommadossi Jean-Pierre | President | SELL | $100K–$500K | 57K | $3.85 | Feb 3, 2024 |
| Horga Maria Arantxa | Chief Medical Offi… | EXERCISE | N/A | 42K | — | Feb 3, 2024 |
| Horga Maria Arantxa | Chief Medical Offi… | SELL | $50K–$100K | 16K | $3.84 | Feb 3, 2024 |
| Foster Wayne | EVP | SELL | $15K–$50K | 12K | $3.84 | Feb 3, 2024 |
| Foster Wayne | EVP | EXERCISE | N/A | 33K | — | Feb 3, 2024 |
| Vavricka John | Chief Commercial O… | SELL | $15K–$50K | 12K | $3.84 | Feb 3, 2024 |
| Vavricka John | Chief Commercial O… | EXERCISE | N/A | 33K | — | Feb 3, 2024 |
| Hammond Janet MJ | Chief Development … | EXERCISE | N/A | 47K | — | Feb 3, 2024 |
| Hammond Janet MJ | Chief Development … | SELL | $50K–$100K | 14K | $3.84 | Feb 3, 2024 |
| BERGER FRANKLIN M | Director | SELL | $100K–$500K | 42K | $5.15 | Nov 16, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 81 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| BML Capital Management, LLC | 7.5M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 4.8M | $1M+ | SH |
| VANGUARD GROUP INC | 3.7M | $1M+ | SH |
| Bain Capital Life Sciences Investors, LLC | 2.5M | $1M+ | SH |
| STATE STREET CORP | 1.8M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 1.3M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.2M | $1M+ | SH |
| JPMORGAN CHASE & CO | 1.2M | $1M+ | SH |
| BlackRock, Inc. | 777K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 608K | $1M+ | SH |
| Peapod Lane Capital LLC | 435K | $1M+ | SH |
| CM Management, LLC | 355K | $1M+ | SH |
| BANQUE PICTET & CIE SA | 345K | $1M+ | SH |
| BARCLAYS PLC | 243K | $500K+ | SH |
| HSBC HOLDINGS PLC | 241K | $500K+ | SH |
| MORGAN STANLEY | 209K | $500K+ | SH |
| GOLDMAN SACHS GROUP INC | 183K | $500K+ | SH |
| Auour Investments LLC | 177K | $500K+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 9, 2026
9.6%
7.5M shares
SC 13G/A · Dec 5, 2025
11.6%
9.1M shares
SC 13G/A · Aug 6, 2025
6.7%
5.7M shares
SC 13G/A · May 14, 2025
6.9%
5.9M shares
SC 13G/A · Apr 24, 2025
7.1%
6.1M shares
SC 13D/A · Apr 17, 2025
0.2%
185K shares
SC 13D/A · Mar 21, 2025
0.2%
175K shares
SC 13D · Mar 4, 2025
0.2%
165K shares
SC 13G/A · Feb 14, 2025
4.0%
3.3M shares
SC 13D · Dec 16, 2024
8.1%
6.8M shares
SC 13G/A · Nov 15, 2024
6.4%
5.4M shares
SC 13G/A · Nov 12, 2024
7.8%
6.6M shares
SC 13G/A · Feb 15, 2024
8.4%
7.0M shares
SC 13G/A · Feb 15, 2024
8.4%
7.0M shares
SC 13G/A · Feb 15, 2024
8.4%
7.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.5%
4.6M shares
SC 13G/A · Feb 13, 2024
7.1%
5.9M shares
SC 13G/A · Jan 24, 2024
11.3%
9.4M shares
SC 13D/A · Nov 28, 2023
4.8%
4.0M shares
SC 13G/A · Nov 7, 2023
10.6%
8.8M shares
SC 13G/A · Sep 11, 2023
8.5%
7.1M shares
SC 13D · May 22, 2023
3.6%
3.0M shares
SC 13G/A · Feb 10, 2023
7.1%
5.9M shares
SC 13G/A · Feb 10, 2023
7.4%
6.2M shares
SC 13G/A · Jan 24, 2023
9.6%
8.0M shares
Morningside Venture Investments Ltd
SC 13G/A · Feb 16, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
0.4%
300K shares
SC 13G/A · Feb 10, 2022
7.2%
5.9M shares